Clinical Trial Update: Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bevacizumab, fluorouracil, and hydroxyurea in combination with radiation therapy for advanced head and neck cancer. The study has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity | Phase 1 | Status: COMPLETED